Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 8;14(1):74.
doi: 10.3390/jpm14010074.

The Impact of Clinical Pharmacist Diabetes Education on Medication Adherence in Patients with Type 2 Diabetes Mellitus: An Interventional Study from Khartoum, Sudan

Safaa Badi  1 , Sara Zainelabdein Suliman  1 , Rayan Almahdi  1 , Mohammed A Aldomah  1 , Mohamed ELsir Marzouq  1 , Eiman Eltayeb M Ibrahim  1 , Musaab Ahmed  2 , Mohamed H Ahmed  3   4 , Habab Khalid Elkheir  1   5 , Mohamed Izham Mohamed Ibrahim  6
Affiliations

The Impact of Clinical Pharmacist Diabetes Education on Medication Adherence in Patients with Type 2 Diabetes Mellitus: An Interventional Study from Khartoum, Sudan

Safaa Badi et al. J Pers Med. .

Abstract

Background: Continuous therapeutic care with good medication adherence is the cornerstone of management of all chronic diseases including diabetes. This study aimed to evaluate the impact of clinical pharmacist intervention on the medication adherence in individuals with type 2 diabetes (T2DM).

Methods: This was a randomized, double-blind, controlled trial conducted at a diabetes clinic located at Omdurman Military Hospital, Sudan. Individuals with T2DM attending the diabetes clinic within 1 year were selected. The sample size was 364 participants (182 control and 182 interventional group). We used a pre-structured standardized questionnaire and checklist to collect the data. Data were analyzed by using the Statistical Package for the Social Sciences (SPSS) (version 28).

Results: Majority, 76.4% (n = 278) were females, and they consisted of 80.8% (n = 147) of the interventional group and 72% of the controls. The mean age of the interventional group was 54.5 (±10) years; 31.9% (n = 58) of the interventional group had diabetes for 6-10 years, compared with 26.4% (n = 48) of the control group. Among the control group, the mean adherence score was 6.8 (±1.7) at baseline and it was 6.7 (±1.6) at the end of the study (p < 0.001), while in the interventional group, the mean adherence score was 6.8 (±1.7) at baseline and it was 7.4 (±1.5) at the end of the study (p < 0.001).

Conclusion: Adherence score among the intervention group was increased significantly from baseline to the end of the study when compared to the control group.

Keywords: adherence; clinical pharmacists; diabetes; medications.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. World Health Organization (WHO) ‘Diabetes’, WHO. [(accessed on 1 July 2021)]. Available online: https://www.who.int/health-topics/diabetes#tab=tab_1.
    1. Toth-Manikowski S., Atta M.G. Diabetic kidney disease: Pathophysiology and therapeutic targets. J. Diabetes Res. 2015;2015:697010. doi: 10.1155/2015/697010. - DOI - PMC - PubMed
    1. IDF Diabetes Atlas. 9th ed. International Diabetes Federation; Brussels, Belgium: 2019. International Diabetes Federation, ‘prevalence of diabetes’; pp. 3–4.
    1. García-Pérez L.E., Álvarez M., Dilla T., Gil-Guillén V., Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013;4:175–194. doi: 10.1007/s13300-013-0034-y. - DOI - PMC - PubMed
    1. Monnette A., Zhang Y., Shao H., Shi L. Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review. Pharmacoeconomics. 2017;36:19. doi: 10.1007/s40273-017-0570-9. - DOI - PubMed

LinkOut - more resources